Basic income of 0.26 yuan per share. The first half of the Pharmaceutical plate performance | The company's shareholders list funds holding group

Medical Network August 15 medical unit as the first half of the most powerful plate, performance expectations. As of August 14 20 o'clock, a total of 61 pharmaceutical companies disclosed semi-annual reports, of which more than 80% of the companies achieved growth, and more than half of the company's net profit growth of more than 30%.

and the plate is the capital bullish, the phenomenon of institutional overweight is also more obvious, including ' Connections ' ' Brothers Fund ' holding Group Holdings. From Kin-Pal shares semi-annual report, its top ten circulating stock shareholder institutions gathered.

Public offering fund, on investment Morgan domestic demand power, Xing full run grading, Cathay Pacific jinlong Industry, Wang Tak Vision, easy to reach health care, such as one by one in the column, the risk of China life insurance under the two insurance products and securities companies Citic Jian investment security also appeared among them. Kin-Sumitomo is one of the major producers of heparin in China. In the first half of 2018, the company realized operating income of 850 million yuan, an increase of 75.65%; Net profit of 227 million yuan, an increase of 84.24% per cent;

Earnings per share of 0.41 yuan. As China's largest pharmaceutical Enterprise One, North China Pharmaceutical 2018 the first half of the year to achieve revenue 4.719 billion yuan, an increase of 17.87%; Achieve net profit of 62 million yuan, an increase of 100.67% per cent;

Earnings per share of 0.04 yuan. Semi-annual reports show that the company's Top 14 circulating shareholders, 10 of the Special management plan for the company, total shareholding 167 million, accounting for the total capital of 10.26%. Kin-sail Biology in the first half of the stock price and performance are extraordinary, and access to a number of funds overweight. Kin-sail Biology in the first half of 2018 to achieve revenue 456 million yuan, an increase of 38.91%; Net profit of 210 million yuan, an increase of 40.9% per cent; Earnings per share of 0.51 yuan. Two quarter to add rich Medicine Health Mixing, and adding rich medical services, Investment

Core value mixed 3 funds to buy 2.32 million shares, 1.95 million shares and 1.72 million shares, the new into the top ten circulating shareholders of the health-sail biology. Tonghua Dongbao is favored by the North Fund and Social Security Fund. North funds continue to the first half of Tonghua Dongbao to increase holdings, the number reached 16.56 million shares, the total number of shares to 126 million shares, ranked the top ten shareholder list second. The National Social Security Fund 117 combination, the National Social Security Fund 115 combination, in the reporting period also to the Tonghua Dongbao to increase the 4.3247 million shares and 3.6117 million shares respectively, the shareholding quantity increased to 31.9484 million shares and 17.52 million shares respectively,

And the stock number of 20.7104 million shares of the National Social Security Fund 416 group of companies listed in the top ten shareholders list. Semi-annual report shows that Tonghua Dongbao 2018 years on the half of the operating income of 1.463 billion yuan, an increase of 23.85%; Achieve net profit of 537 million yuan, an increase of 30.78% per cent;